Divis Laboratories reported a reduction of 13,500 tonnes of CO2 equivalent in greenhouse gas emissions for FY 2025-26, alongside conserving 159,500 kiloliters of water. The company also had its net-zero targets for FY 2050 validated by the Science Based Targets initiative (SBTi), a key step for aligning with the Paris Agreement. The pharma firm maintained a lost time injury severity rate of 0.14, indicating safety improvements alongside environmental gains. The announcement comes as part of broader sustainability reporting, but lacks detail on the specific capital expenditures or operational changes that drove the emissions cuts. For investors and climate analysts, the SBTi validation adds credibility, but the real test will be whether Divis can maintain this trajectory through FY 2034 and beyond. Scope 3 supply chain engagement and replication of Zero Liquid Discharge systems across other plants remain open questions.
